March 29, 2013: Added Chinese hearing implant maker takes aim at Cochlear America's "virtual monopoly".
September 18, 2012: Added article on human stem cell treatment being developed as a future alternative to cochlear implants.
August 12, 2012: Added Reuters announcement that Cochlear Americas profit slid near 70 percent following the recall last September of its Nucleus CI500 device. Cochlear, which controls over two-thirds of the market, expects to relaunch the device in the near future. The failure rate of other Nucleus devices has more than doubled since last December.
July 1, 2012: Added Cochlear Americas announcement that the Food and Drug Administration approved their Nucleus CI422 device, which contains the thinnest full-length electrode.
April 12, 2012: Added the American Speech Language Hearing Association advocacy update for 2011-2012 showing that "ASHA does not take a position" on the Patient Protection and Affordable Care Act (PPACA), which will ensure access to cochlear implants to the tens of thousands unable to access this "miracle" technology due to costs. Other hearing loss associations and cochlear implant manufacturers have also not taken a position on the critical consumer protections in the PPACA for those with costly communication disorders.
June 10, 2010: The U.S. Department of Justice announces that Cochlear Americas will pay $950,000 to avoid prosecution for violating the federal Anti-Kickback statute. Former Chief Financial Officer Brenda March had brought a 2004 whistleblower lawsuit against Cochlear Americas documenting that the world's largest manufacturer of cochlear implants made illegal payments to physicians in exchange for referring only Cochlear devices to patients. The Patient Protection and Affordable Care Act will require such payments to be publicly disclosed in future years.
March 27, 2010: Added link to new study showing that children with cochlear implants have quality of life equal to hearing peers.
November 9, 2009: Swiss hearing aid company Sonova Holding AG expands into cochlear implants by purchasing Advanced Bionics Corporation for US$489 million.
September 14, 2008: Added webpage announcing Congressional passage of ADA Restoration Act (S.3406) restoring provisions of the Americans with Disabilities Act (ADA) that were largely gutted by recent U.S. Supreme Court decisions. This new law means that disability must now be determined without regard to any mitigating drugs or devices (such as cochlear implants).
December 14, 2007: Added decision by Nova Scotia Department of Health to begin covering bilateral cochlear implants.
November 12, 2007: Added unsealed whistleblower complaint filed against Cochlear Americas by former CFO Brenda March for illegal kickbacks that (per the 2002 study by RAND) controlled the referral patterns of physicians and kept the price of cochlear implants so artifically high that many deafened candidates are forced to remain in a world of silence.
October 27, 2007: Added Aetna policy including coverage for bilateral cochlear implants effective October 19, 2007.